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Background: The importance of diabetes mellitus (DM) as an independent risk factor for perioperative cardiac morbidity
after vascular surgery is controversial. This study examined the impact of DM on perioperative outcomes and length of
stay in patients who underwent major vascular surgery.
Methods: Patients who underwent elective aortic reconstruction (n  2792), lower extremity bypass (n  3838), carotid
endarterectomy (n  5522), and major amputation (n  3883) from 1997 to 1999 were identified in the National
Surgical Quality Improvement Program database of the Department of Veterans Affairs. Outcomes assessed were death,
cardiovascular complications (myocardial infarction, stroke, need for cardiopulmonary resuscitation), and length of stay.
Multivariable logistic and linear regression models were used to control for patient demographics, procedure type,
comorbidities, and diabetic complications.
Results: Before adjustment for potential confounders, patients with diabetes had a higher incidence rate of perioperative
death (3.9% versus 2.6%; P  .001) and cardiovascular complications (3.3% versus 2.6%; P  .01) when compared with
patients without diabetes. After controlling for comorbid conditions, procedure type, and diabetic complications, only
patients with DM who underwent treatment with insulin were at statistically increased risk for cardiovascular complica-
tions (odds ratio [OR], 1.48; 95% CI, 1.15 to 1.91). Neither DM treated with insulin (OR, 1.10; 95% CI, 0.85 to 1.41)
nor DM treated with oral medications (OR, 0.96; 95% CI, 0.73-1.28) was an independent risk factor for death.
Important independent risk factors for death included several conditions that are commonly associated with diabetes,
including proteinuria, elevated creatinine level, history of congestive heart failure, and history of cerebrovascular
accident. DM was also found to increase length of stay by as much as 38% even after adjustment for comorbidities.
Conclusion: Patients with diabetes have a higher incidence rate of death and cardiovascular complications. However, after
controlling for specific comorbid conditions, the only independent association was between patients with insulin
treatment and the risk of cardiovascular complications. DM does not appear to be an independent risk factor for
postoperative mortality. All patients with diabetes, regardless of insulin use, have a prolonged length of stay after major
vascular surgery. (J Vasc Surg 2002;35:894-901.)
Perioperative cardiovascular morbidity and mortality
continue to be the leading cause of death and complications
after major vascular surgery. Consequently, considerable
attention has been paid to the identification of risk factors
associated with increased cardiac complications. Patients
with diabetes mellitus (DM) have frequently been consid-
ered to have an elevated risk of cardiac complications
compared with patients without diabetes, which justifies a
lower threshold for cardiac stress testing.1 Diabetes has
been classified by the American College of Cardiology/
American Heart Association guidelines as an intermediate
risk factor that mandates further evaluation in patients who
have decreased functional status or are scheduled for high
risk surgery, including aortic and peripheral vascular proce-
dures.2
Previous evaluations of the risk of patients with diabetes
who undergo specific vascular surgery have not always
supported the finding that patients with diabetes are at
increased perioperative risk. After controlling for other
identified comorbidities with multivariate analysis, some
studies have suggested that patients with diabetes do not
appear to be at increased risk of death after carotid endar-
terectomy3,4 or aortic surgery.5-7 However, other studies
have suggested that an increased risk of perioperative com-
plications exists among patients with diabetes who undergo
aortic surgery.6 Most evaluations of this issue have suffered
from a small number of adverse outcomes (thus limiting
statistical power) and incomplete documentation of impor-
tant comorbidities. Furthermore, despite evidence that the
risk of death after coronary artery bypass grafting may vary
among patients with diabetes depending on severity of
disease,8 the impact of risk stratification by degree of dia-
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betic complications (eg, the need for insulin or presence of
nephropathy) has not been investigated in patients who
undergo noncardiac vascular surgery.
This investigation examined the independent risk of
DM on mortality, cardiovascular morbidity, and length of
stay (LOS) in patients who underwent vascular surgery.
Analyses controlled for comorbid disease, the severity of
DM as determined by the need for oral medications or
insulin, and the incidence rate of renal complications of
DM. The goal of the investigation was to evaluate the
hypothesis that the risk of poor outcome is not uniformly
high across all patients with DM, and, in the absence of
other identifiable risk factors, invasive testing could be
limited to patients with diabetes who are identified before
surgery as high risk.
MATERIALS AND METHODS
Data sources. All patients who underwent major vas-
cular surgical procedures from 1997 through 1999 were
identified from the Department of Veterans Affairs (VA)
Patient Treatment File (PTF) database. Data were ab-
stracted for patients who underwent four types of proce-
dures with International Classification of Diseases, 9th
Revision, Clinical Modification codes: abdominal aortic
reconstruction (38.44, 39.25), carotid endarterectomy
(38.12, 38.32, 38.42), lower extremity bypass (39.29), and
lower extremity major amputation (84.10, 84.15, 84.16,
84.17, 84.18). PTF data included demographic informa-
tion, condition of patient at discharge, and hospital LOS.
Patient records then were linked to the National Surgi-
cal Quality Improvement Program (NSQIP) database of
surgical procedures performed at VA hospitals. The NSQIP
is a prospective, multicenter observational evaluation
project to assess risk-adjusted surgical outcomes within the
VA as described in detail elsewhere.9,10 This clinical data-
base includes patient demographic information, preopera-
tive comorbidities, intraoperative care, and postoperative
outcomes collected by trained surgical clinical nurse re-
viewers at each of 123 surgical centers. All operations
performed with general, spinal, and epidural anesthesia are
included in the database unless the patient has been entered
into the database for another index procedure within the
previous 30 days.
Patients also were matched to a diabetes registry col-
lected as part of the national VA Quality Enhancement
Research Initiative (QUERI) in diabetes care.11 The
QUERI database includes information on hospitalizations,
outpatient visits, selected pharmaceuticals, and all labora-
tory data for selected tests completed on inpatients and
outpatients in the VA system. Where available, these data
were used to determine patient diabetic medication, preop-
erative serum creatinine level, hemoglobin A1c, and degree
of proteinuria.
Data linkage was accomplished with scrambled patient
identifiers, date of admission, and procedure type. Patient
confidentiality was ensured with removal of all patient
identifiable information, including scrambled identifiers,
after linkage. All patient identifiable data were maintained
in secured systems within the VA and were not provided to
the study investigators. This project was approved by the
Institutional Review Committee of the VA Ann Arbor
Health Care System.
Definition of surgical procedures. Patients were
classified into one of four mutually exclusive classifications
on the basis of procedure type with the following hierarchy:
aortic reconstruction, carotid endarterectomy, lower ex-
tremity bypass, and amputation. Therefore, if a patient
underwent both an aortic repair and a lower extremity
bypass, the patient was considered in the aortic repair
category. Importantly, patients whose primary procedure
was classified as emergent within the NSQIP database were
excluded.
Definition of independent variables. Demographic
information collected from the PTF file included patient
age, race, and sex. Subjects were considered to have DM if
they had any of the following conditions: receipt of insulin
or oral hypoglycemic medications before admission; outpa-
tient visits, including a diagnosis of DM on two occasions;
or a previous inpatient stay with a discharge diagnosis of
DM. The DM classification was divided into three catego-
ries: insulin-treated DM, oral-treated or diet-treated DM,
and no DM. Because the vast majority of patients within the
VA have type 2 DM, it should be noted that most of the
patients treated with insulin in this study have type 2
diabetes. The databases are unable to identify which pa-
tients with insulin treatment have type 1 diabetes, but
unpublished audits of the QUERI diabetes registry suggest
that less than 3% of VA patients with DM have type 1 DM.
Additional independent variables were defined with
NSQIP definitions: history of congestive heart failure
within 1 month of surgery; history of chronic obstructive
pulmonary disease resulting in 1 or more of conditions of
functional disability, chronic bronchodilator therapy, or
forced expiratory volume in 1 second of less than 75% of
predicted; history of a transient ischemic attack; history of a
cerebrovascular accident (embolic, thrombotic, hemor-
rhage) with residual motor, sensory, or cognitive deficit;
ethanol abuse of greater than two drinks per day in the 2
weeks before admission; current smoker; ventilator use
before surgery; steroid therapy before surgery; and dialysis
before surgery. Further details can be found in previous
published reports from the NSQIP project.12 In addition,
because the NSQIP data did not contain a field for hyper-
tension, patients were classified as hypertensive on the basis
of identification of a diagnostic code for hypertension in
prior inpatient or outpatient evaluations (PTF database).
Preoperative laboratory data were examined for evi-
dence of chronic renal insufficiency, proteinuria, and poorly
controlled DM. An elevated creatinine level, identified with
the NSQIP set, was considered to be greater than or equal
to 2.0. Proteinuria was defined as a value of 2 or greater
on dipstick, greater than 30 mg/24 hours on urine collec-
tion, or greater than 100 g/mL. Patients without preop-
erative laboratory values were assigned normal values in
multivariate analysis. This was on the basis of the finding
that most patients have normal values and the assumption
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that routine laboratory tests were not obtained in healthier
patients, who would be more likely to have normal values.
Preoperative urine protein values were available for 47% of
patients with diabetes (42% of all patients), and preopera-
tive creatinine values were recorded for 94% of patients with
diabetes (94% of patients overall).
Because this investigation was designed to improve
preoperative risk stratification on the basis of the severity of
diabetes, only variables that would be available to the
clinician before surgery were included in the model. There-
fore, we did not include intraoperative and postoperative
data that had been collected in the NSQIP or diabetes
registry in our model. Besides proteinuria and hemoglobin
A1c data, no data element was missing for more than 3.6%
of the population.
Definition of surgical outcomes. The three primary
outcomes assessed in this analysis were defined with NSQIP
data. Death was defined with the condition of patient at
discharge. Cardiovascular complications were defined as
acute myocardial infarction that occurred during surgery or
within 30 days of surgery, cardiac arrest necessitating car-
diopulmonary resuscitation in the operating room, inten-
sive care unit (ICU), ward, or out-of-hospital within 30
days, or an embolic, thrombotic, or hemorrhagic cardiovas-
cular accident with motor, sensory, or cognitive dysfunc-
tion within 30 days.12 The combined outcome was defined
as death or cardiovascular complication or both.
Statistical analysis. Differences in baseline character-
istics and clinical outcomes among patients with and with-
out diabetes were evaluated with 2 testing for categoric
variables and two-tailed Student t tests for continuous
variables. Subsequently, multivariable logistic regression
models were developed for each of the three primary out-
comes. The model was developed with sequentially adding
progressively more detailed clinical variables. The indepen-
dent association of insulin-treated or orally treated diabetes
with surgical outcomes was determined after sequentially
adjusting for (1) procedure type, (2) patient demographics,
and (3) general comorbidities. A subsequent model was
developed for the subset of patients with diabetes that
examined proteinuria and elevated glycosylated hemoglo-
bin to determine their prognostic significance. Finally, the
impact of DM on hospital LOS and ICU LOS was deter-
mined with linear regression. To account for the significant
right skew in LOS and ICU LOS data, the data were
transformed with logarithm as the dependant variable.
Model performance was assessed with formal good-
ness-of-fit (Hosmer-Lemonshow) tests.13 The Hosmer-
Lemeshow test compares the expected and observed events
in 10 equal subgroups defined by the deciles of predicted
risk. A statistically nonsignificant goodness of fit statistic is
evidence of model discriminant capacity. All models
showed evidence of excellent model calibration with both
visual and statistical inspection. Appropriate first-degree
interaction terms were examined and did not improve
model fit as assessed with receiver operating curve values,
including interaction terms between procedure type and
diabetes. Data were analyzed with Stata v. 6.0 (Stata Cor-
poration, College Station, Tex).
RESULTS
Records for 17,290 major vascular surgical procedures
in the nation’s VA hospitals were available for review. After
exclusion of patients who underwent emergency operations
(n 1250), a total was left of 14,525 unique patients who
underwent 16,035 procedures. Patients with DM consti-
tuted 49% of these patients, of whom 42% were undergoing
treatment with insulin before operation and 35% were
undergoing treatment with oral hypoglycemic agents
alone.
Patient characteristics differed significantly among pa-
tients with and without diabetes (Table I). In particular,
patients with diabetes were older, were less likely to be
white, and had a significantly higher incidence rate of
important comorbid conditions. In addition, patients with
diabetes were less likely to smoke, use alcohol, have chronic
obstructive pulmonary disease, or have had a stroke.
Before adjustment for patient factors, patients with
diabetes who underwent vascular procedures were found to
have a higher incidence rate of the combined outcome of
death or cardiovascular complications (5.8% versus 4.3%;
P  .001), death alone (3.9% versus 2.6%; P  .001), and
cardiovascular complications (3.3% versus 2.6%; P  .011;
Table II). A higher rate of the combined outcome (death or
cardiovascular complications) also was found with individ-
Table I. Characteristics of patients undergoing major
vascular surgical procedures in VA hospitals from 1997 to
1999
Patients
with
DM
Patients
without
DM P value
No. 7871 8164
Age (y) 67.6  9 66.8  9 .001
Male gender 99.0% 98.8% .257
White race 74.4% 84.0% .001
Hypertension 87.7% 79.6% .001
History of stroke with neuro 14.1% 17.4% .001
History of stroke without neuro 7.6% 6.5% .019
History of transient ischemia attack 12.6% 17.9% .001
Congestive heart failure 8.1% 3.2% .001
Chronic obstructive pulmonary
disease
17.8% 22.0% .001
Creatinine level 2.0 12.5% 4.3% .001
Dialysis 5.6% 0.8% .001
Ventilation before surgery 0.4% 0.4% .910
Smoker 36.3% 54.7% .001
Active use of ethanol 6.8% 13.6% .001
Steroid use 2.4% 2.5% .600
Proteinuria 18.9% 5.9% .001
DM necessitating insulin 41.5% N/A
DM necessitating oral medication 34.7% N/A
HbA1c 6.2 - 8.0 15.0% N/A
HbA1c 8.0 - 9.5 10.9% N/A
HbA1c  9.5 10.9% N/A
HbA1c-missing 52.0% N/A
N/A, Not applicable; neuro, neurologic deficit; HbA1c, hemoglobin A1c.
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ual vascular operations for patients with DM who under-
went both carotid endarterectomy (3.5% versus 2.5%; P 
.027) and lower extremity bypass (4.4% versus 2.7%; P 
.007).
However, analysis of the combined outcome (death or
cardiovascular complications) revealed that only patients
with diabetes who needed insulin treatment were at higher
risk of death or cardiovascular complications when com-
pared with patients without diabetes (odds ratio [OR],
1.37; P .001) after adjustment for patient demographics
(age, sex, and race) and procedure type (Table III). After
adjustment for confounding comorbidities, patients with
oral hypoglycemic treatment alone did not have a signifi-
cantly greater risk of death or complications (OR, 1.15; P
.18), and patients with diabetes who needed insulin treat-
ment appeared to be at a mildly increased risk of the
combined outcome (death or nonfatal cardiovascular com-
plication; OR, 1.22; P  .06). Comorbid conditions that
predicted a higher odds of postoperative death or cardio-
vascular complication included increased age, history of
stroke with neurologic deficit, chronic obstructive pulmo-
nary disease, steroid use, preoperative ventilation, conges-
tive heart failure, and elevated creatinine level. In this data
set, those patients with a clinical diagnosis of hypertension
had a lower risk of an adverse outcome (OR, 0.75; P 
.005).
Similar findings were evident when the association be-
tween diabetes and the risk of death was examined sepa-
rately from nonfatal complications (Table IV). Patients
with insulin-treated DM were at increased risk of death
after adjustment for demographic factors and procedure
type (OR, 1.25; P  .046), but no residual effect was seen
after accounting for other comorbidities and renal insuffi-
ciency (OR, 1.10; P  .45).
Patients with diabetes with insulin treatment also had a
significant increase in the odds of development of postop-
erative nonfatal cardiovascular complications (Table V).
After adjustment for demographic factors and procedure
type, diabetes treated with insulin had an OR of 1.71 (P 
.001). Inclusion of other known comorbidities, including
renal insufficiency, into the model reduced, but did not
eliminate, the independent association between diabetes
needing insulin and a greater risk of cardiovascular compli-
cations (OR, 1.48; P .002). However, patients with oral
hypoglycemic agent treatment alone were not at signifi-
cantly increased risk (OR, 1.22; P .14) for cardiovascular
complications. Comorbid conditions that did predict
higher odds of postoperative cardiovascular complications
included a history of stroke with neurologic deficit, conges-
tive heart failure, and elevated creatinine level.
In a subset analysis including only patients with diabe-
tes, patients who underwent treatment with insulin had a
trend toward higher rates of cardiovascular complications
(OR, 1.28; P  .10) but not death or the combined
outcome (Table VI). This analysis is consistent with the
findings of the overall analysis, in that it suggests that
insulin-treated diabetes is a minor risk factor for cardiovas-
cular complications but not death and that non–insulin
treated DM is not an independent risk factor at all. Also
consistent with the overall analysis, other clinical risk factors
are more predictive of perioperative morbidity and mortal-
ity, including stroke with neurologic deficit, preoperative
ventilation, steroid use, and chronic renal failure. Signifi-
cant proteinuria is a marker of an increased risk of death
Table II. Death or cardiovascular complications of major vascular procedures performed in VA hospitals from 1997 to
1999
Patients with DM Patients without DM P value
Vascular procedures performed
Carotid endarterectomy 2210 (40%) 3312 (60%)
Aortic reconstruction 744 (27%) 2048 (73%)
Lower extremity bypass 2120 (55%) 1718 (45%)
Amputation 2797 (72%) 1086 (28%)
Death or cardiovascular complication
All procedures 458 (5.8%) 352 (4.3%) .001
Carotid endarterectomy 78 (3.5%) 83 (2.5%) .027
Aortic reconstruction 39 (5.2%) 118 (5.8%) .600
Lower extremity bypass 93 (4.4%) 47 (2.7%) .007
Amputation 248 (8.9%) 104 (9.6%) .49
Death
All procedures 304 (3.9%) 212 (2.6%) .001
Carotid endarterectomy 19 (0.9%) 18 (0.5%) .16
Aortic reconstruction 22 (3.0%) 73 (3.6%) .43
Lower extremity bypass 57 (2.7%) 32 (1.9%) .09
Amputation 206 (7.4%) 89 (8.2%) .38
Non-fatal cardiovascular events
All procedures 260 (3.3%) 214 (2.6%) .011
Carotid endarterectomy 75 (3.4%) 77 (2.3%) .017
Aortic reconstruction 25 (3.4%) 76 (3.7%) .66
Lower extremity bypass 63 (3.0%) 24 (1.4%) .001
Amputation 97 (3.5%) 37 (3.4%) .92
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(OR, 1.44; P  .02). We then used this analysis to stratify
the diabetic population. We considered patients with dia-
betes at high risk if they had any of the previous major
independent risk factors. With this criterion, the patients
with diabetes at high risk represent 44% of the entire
population. Among patients with non–insulin treated dia-
betes, only 39% of patients had preoperative risk factors for
cardiovascular complications.
Finally, we examined the effect of DM on hospital
resource use. In bivariate comparisons, patients with DM
Table III. Impact of diabetes on risk of combined outcome (death or cardiovascular complications) after vascular
surgical procedures
Combined outcome (OR; 95% CI)
Adjusted for procedure type
Additionally adjusted for
demographic factors
Additionally adjusted for
comorbidities
Risk factor
Insulin-treated DM 1.31 (1.09 - 1.56)* 1.37 (1.13 - 1.64)* 1.22 (0.99 - 1.49)
Oral-treated DM 1.10 (0.89 - 1.35) 1.07 (0.87 - 1.32) 1.15 (0.93 - 1.43)
AAA 0.66 (0.53 - 0.82)* 0.74 (0.59 - 0.92)* 0.97 (0.77 - 1.22)
Carotid 0.32 (0.27 - 0.40)* 0.33 (0.26 - 0.40)* 0.40 (0.32 - 0.51)*
Lower extremity bypass 0.40 (0.32 - 0.49)* 0.43 (0.35 - 0.53)* 0.53 (0.43 - 0.65)*
Age 1.04 (1.03 - 1.05)* 1.04 (1.03 - 1.05)*
Race not white or black 1.32 (1.02 - 1.70)†
Black race 0.83 (0.66 - 1.03)
Ventilation 5.62 (3.12 - 10.1)*
Creatinine level 2.0 2.15 (1.68 - 2.70)*
CHF 1.98 (1.56 - 2.50)*
Steroid therapy 1.56 (1.06 - 2.29)†
Stroke with neuro deficit 1.56 (1.29 - 1.88)*
COPD 1.18 (0.99 - 1.42)
Hypertension 0.75 (0.62 - 0.92)*
C-statistic  0.72.
Variables not shown (P  .10): sex, smoking, alcohol use, prior stroke without neurologic deficit, history of transient ischemic attack. Amputation was
used as comparison procedure.
OR  1.0.
*P  .01.
†P  .05.
AAA, Abdominal aortic aneurysm; neuro deficit, neurologic deficit; COPD, chronic obstructive pulmonary disease; CHF, congestive heart failure.
Table IV. Impact of diabetes on risk of death after vascular surgical procedures
Death (OR; 95% CI)
Adjusted for procedure type
Additionally adjusted for
demographic factors
Additionally adjusted for
comorbidities
Risk factor
Insulin-treated DM 1.18 (0.95 - 1.47) 1.25 (1.00 - 1.56)† 1.10 (0.85 - 1.41)
Oral-treated DM 0.89 (0.69 - 1.17) 0.99 (0.77 - 1.30) 0.96 (0.73 - 1.28)
AAA 0.45 (0.35 - 0.59)* 0.50 (0.39 - 0.66)* 0.68 (0.51 - 0.91)*
Carotid 0.08 (0.06 - 0.12)* 0.08 (0.06 - 0.12)* 0.12 (0.07 - 0.17)*
Lower extremity bypass 0.29 (0.23 - 0.38)* 0.32 (0.25 - 0.42)* 0.42 (0.32 - 0.54)*
Age 1.05 (1.04 - 1.06)* 1.04 (1.03 - 1.06)*
Ventilation 6.94 (3.82 - 12.6)*
Creatinine level  2.0 2.51 (1.88 - 3.38)*
CHF 1.96 (1.48 - 2.59)*
Steroid therapy 1.81 (1.16 - 2.81)*
Stroke with neuro deficit 1.59 (1.26 - 2.02)*
COPD 1.34 (1.07 - 1.67)*
Hypertension 0.71 (0.56 - 0.91)*
C-statistic  0.80.
Variables not shown (P  .10): sex, black race, other race, smoking, stroke without neurologic deficit, hemoglobin A1c level, alcohol use; history of
transient ischemic attack. Amputation was used as comparison procedure.
OR  1.0.
*P  .01.
†P  .05.
AAA, Abdominal aortic aneurysm; CHF, congestive heart failure; neuro deficit, neurologic deficit; COPD, chronic obstructive pulmonary disease.
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had significantly longer LOS. By procedure, patients with
diabetes who underwent abdominal aortic aneurysm repair,
carotid endarterectomy, and lower extremity bypass all had
significantly longer LOS when compared with patients
without diabetes (Table VII). In multivariate analysis con-
trolling for demographic factors, comorbidities, and proce-
dure type, diabetes needing insulin treatment increased
LOS by 25% (P  .001) and diabetes controlled with oral
agents increased LOS by 18% (P  .001), compared with
patients without DM. In addition, longer ICU stays also
were with associated with diabetes needing insulin (9%
increase; P  .001) and diabetes controlled with oral
hypoglycemic agents (10% increase; P  .01; data not
shown).
DISCUSSION
Examination of crude mortality rates, even after adjust-
ment for basic demographic factors and procedure specific
risks, suggests that patients with diabetes have a signifi-
cantly higher rate of complication and death after certain
Table V. Impact of diabetes on risk of nonfatal cardiovascular complications (stroke, myocardial infarction, need for
cardiopulmonary resuscitation) after vascular surgical procedures
Cardiovascular complications (OR; 95% CI)
Adjusted for procedure type
Additionally adjusted for
demographic factors
Additionally adjusted for
comorbidities
Risk factor
Insulin-treated DM 1.65 (1.31 - 2.09)* 1.71 (1.34 - 2.16)* 1.48 (1.48 - 1.91)*
Oral-treated DM 1.24 (0.96 - 1.60) 1.21 (0.93 - 1.56) 1.22 (0.94 - 1.59)
AAA 1.29 (0.96 - 1.61) 1.47 (1.09 - 1.95)* 1.91 (1.41 - 2.58)*
Carotid 0.93 (0.72 - 1.20) 0.96 (0.74 - 1.23) 1.13 (0.85 - 1.52)
Lower extremity bypass 0.70 (0.53 - 0.93)† 0.77 (0.58 - 1.02) 0.92 (0.69 - 1.22)
Age 1.04 (1.03 - 1.05)* 1.04 (1.03 - 1.05)*
Race not white or black 1.56 (1.15 - 2.11)* 1.62 (1.19 - 2.20)*
CHF 2.31 (1.71 - 3.12)*
Creatinine level  2.0 1.74 (1.26 - 2.39)*
Stroke with neuro deficit 1.63 (1.30 - 2.05)*
C-statistic  0.68.
Variables not shown (P  .10): sex, black race, smoking, chronic obstructive pulmonary disease, without neurologic deficit, ventilation, history of
transient ischemic attack, alcohol use, and dialysis. Amputation was used as comparison procedure.
OR  1.0.
*P  .01.
†P  .05.
AAA, Abdominal aortic aneurysm; CHF, congestive heart failure; neuro deficit, neurologic deficit.
Table VI. Cardiovascular death and complications in patients with diabetes
Combined outcome Death
Cardiovascular
complications
Risk factor
Insulin-treated DM 1.09 (0.87 - 1.39) 1.16 (0.85 - 1.57) 1.28 (0.95 - 1.70)
AAA 1.10 (0.69 - 1.73) 0.89 (0.49 - 1.62) 1.78 (1.03 - 3.07)†
Carotid 0.61 (0.43 - 0.85)* 0.16 (0.08 - 0.30)* 1.52 (1.03 - 2.24)†
Lower extremity bypass 0.70 (0.53 - 0.92)† 0.53 (0.37 - 0.75)* 1.24 (0.88 - 1.76)
Age 1.04 (1.02 - 1.05)* 1.04 (1.02 - 1.05)* 1.04 (1.02 - 1.05)*
Ventilation 4.84 (2.10 - 11.1)* 6.40 (2.71 - 15.0)*
Creatinine level  2.0 2.17 (1.59 - 2.97)* 2.57 (1.77 - 3.74)* 1.95 (1.28 - 2.96)*
CHF 2.13 (1.58 - 2.88)* 2.21 (1.55 - 3.15)* 2.24 (1.51 - 3.23)*
Race not white or black 1.65 (1.09 - 2.50)†
Steroid therapy 1.87 (1.07 - 3.28)† 2.32 (1.22 - 4.41)*
Stroke with neuro deficit 1.35 (1.04 - 1.77)† 1.38 (1.00 - 1.93)†
Proteinuria 1.45 (1.06 - 1.97)†
Hypertension 0.50 (0.38 - 0.68)* 0.45 (0.32 - 0.64)* 0.66 (0.44 - 1.00)*
Data shown as OR (95% CI).
Variables shown include insulin status, procedure adjustments, and all comorbid conditions with P  .10. Non–insulin dependent DM and amputation were
used as comparison procedure.
OR  1.0.
*P  .01.
†P  .05.
AAA, Abdominal aortic aneurysm; CHF, congestive heart failure; neuro deficit, neurologic deficit.
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vascular surgery procedures. However, most of this incre-
mental risk reflects the higher levels of specific comorbidi-
ties commonly found in patients with diabetes that can be
easily identified before surgery. Patients with diabetes were
significantly more likely to have congestive heart failure,
renal insufficiency, renal failure needing dialysis, and pro-
teinuria, and each of these were found to be a risk factor for
poor surgical outcome. After controlling for these comor-
bidities, neither insulin-treated nor oral medication–
treated DM appeared to increase the risk of postoperative
death. Complications of DM, including renal insufficiency
and proteinuria, were strong predictors of perioperative
death. In contrast, DM did appear to be a moderate inde-
pendent risk factor for nonfatal cardiovascular complica-
tions, but this increased risk was confined to patients with
diabetes with insulin treatment. Among patients with dia-
betes with insulin treatment, the odds of development of a
nonfatal cardiovascular complication were almost 50%
higher than that of patients without diabetes independent
of other risk factors. Of note, both patients with insulin-
treated and oral agent–treated diabetes had prolonged LOS
when compared with patients without diabetes indepen-
dent of other risk factors.
The finding that DM is not a significant independent
risk factor for perioperative death but is an independent
predictor of postoperative complications may, in part, ex-
plain previous conflicting reports. Although some investi-
gations of carotid endarterectomy3,4 lower extremity by-
pass,14 and aortic aneurysm surgery7 suggest that diabetes
does not convey an increased risk of death, other analyses
do show higher levels of postoperative complications.1,6 To
date, no previous investigation has considered the impact of
diabetes severity, and analysis of comorbidities and compli-
cations has been limited. The need for insulin in type 2 DM,
renal insufficiency, or proteinuria (even in the absence of an
elevated creatinine level) conveys significantly elevated risks
and could be used to identify patients with diabetes at high
risk. Other markers of diabetes severity, including glycosy-
lated hemoglobin level, do not convey increased postoper-
ative risk, even at the highest levels.
Although DM does not appear to independently im-
pact postoperative mortality rates, the significant risk of
long-term cardiac morbidity caused by DM could poten-
tially be used to justify a more aggressive preoperative
evaluation in this setting. In a previous study, DM was
found to significantly increase the odds of death at 4 years
(OR, 1.8; P .03).14 DM also has been found to be one of
two preoperative risk factors that strongly correlated with
late postoperative cardiac events among patients for vascu-
lar surgery followed for 2 years (P .001).15 Although this
analysis suggests the diagnosis of diabetes does not a priori
raise the risk of vascular surgery, this finding should not
decrease physician vigilance in the medical or surgical man-
agement of coronary artery disease and hypertension in
these patients.16
Even with controlling for other cardiovascular risk fac-
tors, patients with diabetes appear to have longer LOS for
each of the surgical procedures examined. In previous
investigations, diabetes increased the LOS among patients
who underwent carotid endarterectomy (6.1 versus 4.8
days; P  .01).4 The increased LOS reported in this study
may reflect the increased complexity of caring for patients
with diabetes (eg, the higher risk of wound complications,
metabolic derangements, and the complexity of medication
management). Given that increased LOS is a marker for
higher resource use, reimbursement for care of patients
with diabetes who undergo vascular procedures should
probably reflect the increased costs associated with their
care, even in the absence of greater risk of postoperative
death.
This investigation is limited by several factors. First,
because this analysis used cohort data, it is possible that
mainly patients with diabetes at lower risk underwent op-
erations. However, given the high incidence rate of other
comorbid diseases found in this population, including end
stage renal disease needing dialysis and congestive heart
failure, it appears unlikely that surgeons were routinely
selecting only healthy patients with diabetes. Second, no
electrocardiographic data were available; therefore, it was
not possible to adjust the analyses for other recognized risk
factors, including symptomatic ventricular arrhythmias,
rapid supraventricular arrhythmias, high-grade atrial ven-
tricular venous block, preexisting q waves, or evidence of
left ventricular hypertrophy.2 However, these factors
would most likely bias the results toward the null hypoth-
esis and are unlikely to increase the independent impact of
Table VII. Impact of diabetes on hospital LOS after major vascular surgery
Increase in LOS (%)*
Diabetes Nondiabetes P value
Diabetes with
insulin
Diabetes with Oral
medications alone
All procedures 21 (11) 13 (7) .001 25% (P  .001) 18% (P  .001)
Carotid endarterectomy 7 (3) 5 (2) .001 17% (P  .01) 14% (P  .03)
AAA repair 16 (10) 14 (9) .031 26% (P  .01) 10% (P  .03)
Lower extremity bypass 22 (13) 16 (8) .001 38% (P  .001) 32% (P  .001)
Amputation 33 (20) 34 (16) .82 18% (P  .001) 6% (P  .22)
Data shown are mean (median) expressed as days.
*Controlling for demographic characteristics, cardiovascular comorbidities, and chronic renal insufficiency.
AAA, Abdominal aortic aneurysm.
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diabetes on cardiac death. The potential exists that this
information could diminish the odds of perioperative car-
diovascular complications among patients with DM who
undergo insulin treatment. Third, the patients considered
in this VA investigation were primarily male, thus limiting
the generalization of these findings to female and nonvet-
eran patients.
In summary, although patients with DM do appear to
be at increased risk after vascular surgery, this risk is princi-
pally a reflection of the higher incidence rate of comorbid
disease in patients with diabetes, particularly congestive
heart failure and chronic renal insufficiency. Cardiovascular
complications are higher in the subgroup of patients with
diabetes who are undergoing insulin treatment, have sig-
nificant proteinuria, or have renal insufficiency. Consider-
ation of special testing to assess perioperative risk should be
targeted to these patients with diabetes at high risk, who
comprised about 40% of patients with diabetes in this study,
rather than applied generally to all patients with DM.
REFERENCES
1. Eagle KA, Coley CM, Newell JB, Brewster DC, Darling RC, Strauss
HW, et al. Combining clinical and thallium data optimizes preoperative
assessment of cardiac risk before major vascular surgery. Ann Intern
Med 1989;110:859-66.
2. Eagle KA, Brundage BH, Chaitman BR, Ewy GA, Fleisher LA, Hertzer
NR, et al. Guidelines for perioperative cardiovascular evaluation for
noncardiac surgery. Report of the American College of Cardiology/
American Heart Association Task Force on Practice Guidelines (Com-
mittee on Perioperative Cardiovascular Evaluation for Noncardiac Sur-
gery). J Am Coll Cardiol 1996;27:910-48.
3. Ballotta E, Da Giau G, Renon L. Is diabetes mellitus a risk factor for
carotid endarterectomy? A prospective study. Surgery 2001;129:146-
52.
4. Akbari CM, LoGerfo FW. Diabetes and peripheral vascular disease. J
Vasc Surg 1999;30:373-84.
5. Berry AJ, Smith RB III, Weintraub WS, Chaikof EL, Dodson TF,
Lumsden AB, et al. Age versus comorbidities as risk factors for compli-
cations after elective abdominal aortic reconstructive surgery. J Vasc
Surg 2001;33:345-52.
6. Treiman GS, Treiman RL, Foran RF, Cossman DV, Cohen JL, Levin
PM, et al. The influence of diabetes mellitus on the risk of abdominal
aortic surgery. Am Surg 1994;60:436-40.
7. Dardik A, Lin JW, Gordon TA, Williams GM, Perler BA. Results of
elective abdominal aortic aneurysm repair in the 1990s: a population-
based analysis of 2335 cases. J Vasc Surg 1999;30:985-95.
8. Brooks MM, Jones RH, Bach RG, Chaitman BR, Kern MJ, Orszulak
TA, et al. Predictors of mortality and mortality from cardiac causes in the
bypass angioplasty revascularization investigation (BARI) randomized
trial and registry. For the BARI Investigators. Circulation 2000;101:
2682-9.
9. Khuri SF, Daley J, Henderson W, Hur K, Gibbs JO, Barbour G, et al.
Risk adjustment of the postoperative mortality rate for the comparative
assessment of the quality of surgical care: results of the National Veter-
ans Affairs Surgical Risk Study. J Am Coll Surg 1997;185:315-27.
10. Daley J, Khuri SF, Henderson W, Hur K, Gibbs JO, Barbour G, et al.
Risk adjustment of the postoperative morbidity rate for the comparative
assessment of the quality of surgical care: results of the National
Veterans Affairs Surgical Risk Study. J Am Coll Surg 1997;185:328-40.
11. Krein SL, Hayward RA, Pogach L, BootsMiller BJ. Department of
Veterans Affairs’ Quality Enhancement Research Initiative for Diabetes
Mellitus. Med Care 2000;38:I38-48.
12. Khuri SF, Daley J, Henderson W, Barbour G, Lowry P, Irvin G, et al.
The National Veterans Administration Surgical Risk Study: risk adjust-
ment for the comparative assessment of the quality of surgical care. J Am
Coll Surg 1995;180:519-31.
13. Lemenshow S, Hosmer DW. A review of goodness of fit statistics for use
in the development of logistic regression models. Am J Epidemiol
1982;115:92-106.
14. L’Italien GJ, Cambria RP, Cutler BS, Leppo JA, Paul SD, Brewster DC,
et al. Comparative early and late cardiac morbidity among patients
requiring different vascular surgery procedures. J Vasc Surg 1995;21:
935-44.
15. Krupski WC, Layug EL, Reilly LM, Rapp JH, Mangano DT. Compar-
ison of cardiac morbidity between aortic and infrainguinal operations.
Study of Perioperative Ischemia (SPI) Research Group. J Vasc Surg
1992;15:354-65.
16. Curb JD, Pressel SL, Cutler JA, Savage PJ, Applegate WB, Black H, et
al. Effect of diuretic-based antihypertensive treatment on cardiovascular
disease risk in older diabetic patients with isolated systolic hypertension.
Systolic Hypertension in the Elderly Program Cooperative Research
Group. JAMA 1996;276:1886-92.
Submitted Apr 16, 2001; accepted Jan 23, 2002.
AVAILABILITY OF JOURNAL BACK ISSUES
As a service to our subscribers, copies of back issues of Journal of Vascular Surgery for the preceding
5 years are maintained and are available for purchase from Mosby until inventory is depleted. Please write
to Mosby, Subscription Customer Service, 6277 Sea Harbor Dr, Orlando, FL 32887, or call 800-654-
2452 or 407-345-4000 for information on availability of particular issues and prices.
JOURNAL OF VASCULAR SURGERY
Volume 35, Number 5 Axelrod et al 901
